Pay in 4 interest-free payments of $43.75 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
46 / Cancer / Bosutinib-d3 / Bosulif-d3
Upon deprotection
and other amine-reactive groups to form stable amide bonds with the Tri-GalNAc ligand
MUC5AC-Tn(3)
PE231000: β-GlcNAc-PEG3-Alkyne Pack Size:100 mg 46 / Cancer / Bosutinib-d3C17H29NO9 391. 41 A D N acetylglucosamine (GlcNAc) ligand equipped with a terminal alkyne through a hydrophilic PEG3 spacer. The alkyne couples to azide functionalized partners via copper catalyzed azide alkyne cycloaddition (CuAAC), forming stable 1,2,3 triazole linkages. This compound provides a N acetylglucosamine (GlcNAc) building block for glycoconjugate synthesis and the construction of probes for GlcNAc recognizing proteins and lectins; it is
